DISQUS

DISQUS Hello! Vytorin Cancer is using DISQUS, a powerful comment system, to manage its comments. Learn more.

Community Page

Jump to original thread »
Author

Vytorin loses market strength … again

Started by BeasleyAllen · 8 måneder dage siden

Clinical trials haven’t been kind to Vytorin, Merck and Schering-Plough’s cholesterol brainchild. The first blow was dealt by the ENHANCE study, which showed Vytorin to be no more effective than much cheaper generic statins. Next came results of the SEAS trial, which indicated ... Continue reading »

0 comments

This thread has no comments yet.

Add New Comment

Returning? Login